These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35868125)
1. Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective. Zhou Z; Zhang J; Zhou E; Ren C; Wang J; Wang Y Eur J Med Chem; 2022 Oct; 240():114595. PubMed ID: 35868125 [TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication. Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343 [TBL] [Abstract][Full Text] [Related]
3. Canonical 3'-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase. Shim J; Larson G; Lai V; Naim S; Wu JZ Antiviral Res; 2003 May; 58(3):243-51. PubMed ID: 12767472 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase. Wu JZ; Yao N; Walker M; Hong Z Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756 [TBL] [Abstract][Full Text] [Related]
5. Current perspective of HCV NS5B inhibitors: a review. Patil VM; Gupta SP; Samanta S; Masand N Curr Med Chem; 2011; 18(36):5564-97. PubMed ID: 22172066 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase. Huang JT; Tseng CP; Liao MH; Lu SC; Yeh WZ; Sakamoto N; Chen CM; Cheng JC J Virol; 2013 May; 87(9):4994-5004. PubMed ID: 23427160 [TBL] [Abstract][Full Text] [Related]
7. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking. Tarannum H; Nandi S Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069 [TBL] [Abstract][Full Text] [Related]
8. Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy. Wu JZ; Hong Z Curr Drug Targets Infect Disord; 2003 Sep; 3(3):207-19. PubMed ID: 14529354 [TBL] [Abstract][Full Text] [Related]
9. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317 [TBL] [Abstract][Full Text] [Related]
10. Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections. Beaulieu PL Curr Opin Investig Drugs; 2007 Aug; 8(8):614-34. PubMed ID: 17668364 [TBL] [Abstract][Full Text] [Related]
11. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives. Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus RNA replication requires a conserved structural motif within the transmembrane domain of the NS5B RNA-dependent RNA polymerase. Brass V; Gouttenoire J; Wahl A; Pal Z; Blum HE; Penin F; Moradpour D J Virol; 2010 Nov; 84(21):11580-4. PubMed ID: 20739529 [TBL] [Abstract][Full Text] [Related]
13. Mutational Analysis of Hepatitis C Virus NS5B in the Subgenomic Replicon Cell Culture. Ma Y; Shimakami T; Luo H; Hayashi N; Murakami S J Biol Chem; 2004 Jun; 279(24):25474-82. PubMed ID: 15037608 [TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase. Ingravallo P; Lahser F; Xia E; Sodowich B; Lai VC; Hong Z; Zhong W Virus Res; 2001 Jun; 75(2):179-87. PubMed ID: 11325472 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase. Pierra Rouvière C; Amador A; Badaroux E; Convard T; Da Costa D; Dukhan D; Griffe L; Griffon JF; LaColla M; Leroy F; Liuzzi M; Loi AG; McCarville J; Mascia V; Milhau J; Onidi L; Paparin JL; Rahali R; Sais E; Seifer M; Surleraux D; Standring D; Dousson C Bioorg Med Chem Lett; 2016 Sep; 26(18):4536-4541. PubMed ID: 27520942 [TBL] [Abstract][Full Text] [Related]
16. Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase. Koch U; Narjes F Infect Disord Drug Targets; 2006 Mar; 6(1):31-41. PubMed ID: 16787302 [TBL] [Abstract][Full Text] [Related]
17. De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. Zhong W; Uss AS; Ferrari E; Lau JY; Hong Z J Virol; 2000 Feb; 74(4):2017-22. PubMed ID: 10644375 [TBL] [Abstract][Full Text] [Related]
18. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations. Manjula S; Sivanandam M; Kumaradhas P J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829 [TBL] [Abstract][Full Text] [Related]
19. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication. Kang SM; Choi SH; Park CY; Kim MH; Kim TK; Park JM; Koh MS; Kang HJ; Hwang SB J Viral Hepat; 2008 Apr; 15(4):305-13. PubMed ID: 18307593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]